Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity
Fragmentation of various extracellular matrix and blood proteins generates antiangiogenic substances that are physiological regulators of angiogenesis. Some of these compounds are in clinical trials as inhibitors of tumor angiogenesis. Anastellin, an antiangiogenic protein fragment derived from fibr...
Shranjeno v:
| izdano v: | Proc Natl Acad Sci U S A |
|---|---|
| Principais autores: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
National Academy of Sciences
2003
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC208775/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/13679585/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.1635112100 |
| Oznake: |
Brez oznak, prvi označite!
|